Advanced search
Publication Cover
Renal Failure Volume 31, 2009 - Issue 3
Submit an article Journal homepage
1,283
Views
1
CrossRef citations to date
0
Altmetric
Clinical Studies

The Role of Pure Diffuse Mesangial Hypercellularity in Patients with Proteinuria

Ioannis Griveas Nephrology Department, 417 Veterans Administration Army Hospital (NIMTS), Athens, GreeceCorrespondence[email protected] [email protected]
,
George Stavianoudakis Nephrology Department, 417 Veterans Administration Army Hospital (NIMTS), Athens, Greece
,
Evagellos Karanikas Nephrology Department, 417 Veterans Administration Army Hospital (NIMTS), Athens, Greece
,
Konstantina Gogos Nephrology Department, 417 Veterans Administration Army Hospital (NIMTS), Athens, Greece
&
Lidia Nakopoulou Pathology Department, Medical School, University of Athens, Athens, Greece
Pages 192-195 | Received 05 Aug 2008, Accepted 03 Dec 2008, Published online: 07 Jul 2009

REFERENCES

  • Churg J, Habib R, White RHR. Pathology of the nephrotic syndrome in children: A report of the International Study of Kidney Disease in Children. Lancet. 1970; 1: 1299–1302
  • White RH, Glaskow EF, Mills RJ. Clinicopathological study of nephrotic syndrome in childhood. Lancet. 1970; 1: 1353–1359
  • Cohen AH, Adher SG. Mesangial proliferative glomerulonephritis. Textbook of Nephrology3rd, SG Massry, RJ Glassock. Williams and Wilkins, Baltimore, Md 1995; 1: 739–742
  • Habib R, Churg J, Berneistein J, al et. Minimal change disease, mesangial proliferative glomerulonephritis and focal sclerosis: Individual entities or a spectrum of disease?. Nephrology, RR Robinson. Springer Verlag, New York 1984; 634–644
  • D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int. 1994; 46: 1223–1241
  • Chen YP, Wang HY, Zou WZ. Non-IgA mesangial proliferative glomerulephritis. Clinical and pathological analysis of 77 cases. Clin Med J. 1989; 102: 510–515
  • Alexopoulos E, Papagianni A, Stangou M, Pantzaki A, Papadimitriou M. Adult-onset idiopathic nephrotic syndrome associated with pure diffuse mesangial hypercellulality. Nephrol Dial Transplant. 2000; 15: 981–987
  • Gavallo T, Johnson MO. Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits. Nephron. 1981; 2: 281–284
  • Yang JY, Melvin T, Sibley R, Michael AF. No evidence for a specific role of IgM deposits. Nephron. 1981; 2: 281–284
  • Nasasdy T, Silva FG, Hogg RJ. Minimal change nephrotic syndrome-focal sclerosis complex (including IgM nephropathy and diffuse mesangial hypercellularity). Renal pathology, with clinical and functional correlations, CC Tisher, BM Brenner. J.B. Lippincott Company, Philadelphia 1994; 330–389
  • Churg J, Sobin LH. Renal disease. Classification and atlas of glomerular diseases. Igaku-Shoin Toky. 1982; 67–82; 127–165
  • White RHR, Glaskow EF, Mills RJ. Clinicopathological study of nephrotic syndrome in childwood. Lancet. 1970; 1: 1353–1359
  • Tune BM, Mendoza SA. Treatment of idiopathic nephrotic syndrome: Regimens and outcomes in children and adults. J Am Soc Nephrol. 1997; 2: 824–832
  • Southwest Pediatric Nephrology Study Group. Childwood nephrotic syndrome associated with diffuse mesangial hypercellularity. Kidney Int. 1983; 24: 87–94
  • International Study of Kidney Disease in Children. Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int. 1981; 20: 765–771
  • Ponticelli C, Rivolta E. Cyclosporine in nephrotic syndrome. Transplant Proc. 1998; 20(Suppl. 4)253–258
  • Tejani A, Nicastri AD. Mesangial proliferative glomerulonephritis. Nephron. 1983; 35: 1–5
  • Cohen AH, Border WA. Mesangial proliferative glomerulonephritis. Semin Nephrol. 1982; 2: 228–240
  • Hirszler P, Yamase HAT, Carney WR, al et. Mesangial proliferative glomerulonephritis with IgM deposits. Clinicopathologic analysisand evidence for morphologic transitions. Nephron. 1984; 38: 100–108
  • Joh K, Matsuyama N, Kanetsuma Y, al et. Nephrotic syndrome associated with diffuse mesangial hypercellularity: Is it heterogeneous disease entity?. Am J Nephrol. 1998; 18: 214–220

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.